维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="WESTON WM"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Rosiglitazone reduces urinary albumin excretion in type 2 diabetes显示文摘	Bakris G Viberti G Weston WM	2003	J Hum Hypertens2003，17，1：	1
2	Rosiglitazone reduces urinary albumin excretion in type Ⅱ diabetes显示文摘	Bakris G Viberti G Weston WM	2003	J Hum Hypertens2003，17，1：	1
3	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular in disease type 2 diabetes mellitus 显示文摘	Haffner SM Greenberg AS Weston WM	2002	Circulation2002，106，：	1
4	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus显示文摘	Haffner SM Greenberg AS Weston WM	2002	Circulation2002，106，6：	1
5	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus 显示文摘	Greenberg AS Weston WM	2002	Circulation2002，106，6：	1
6	Effect of rosiglitazone treatment on nontraditional markers cardiovascular disease in patients with type 2 diabetes mellitus显示文摘	Greenberg AS Weston WM	2002	Circulation2002，106，6：	1
7	Effect of rosiglitazone treatment on nontrational markers of cardiovascular disease in patients with type 2 diabetes mellitus显示文摘	Haffner SM Greenberg AS Weston WM	2002	Circulation2002，106，6：	1
8	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus显示文摘	Haffner SM Greenberg AS Weston WM	2002	Circulation2002，106，：	1
9	Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes显示文摘	Grunberger G Weston WM Patwardhan R	1999	Diabetes1999，48，1：	1
10	Rosiglitazone medidiated reductions in urinary albumin excretion are associated with changes in ambulatory blood pressure in type 2 diabetes patients 显示文摘	Weston WM Heise MA Porter LE	2001	Diabetes2001，50，：	1
11	Effect of rosiglitazone treatment on nontraditional markers cardiovascular disease in patients with type 2 diabetes mellitus 显示文摘	HAFFNER SM GREENBERG AS WESTON WM	2002	Cireulation2002，106，6：	1
12	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus显示文摘	Haffner SM Greenberg AS Weston WM	2002	Circulation2002，106，：	1
13	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type2 Diabetes mellitus显示文摘	Haffner SM Greenberg AS Weston WM		0，，：	1
14	Rosiglitazone reduces urinary albumin excretion in type Ⅱ diabetes显示文摘	Bakris G Viberti G Weston WM	2003	J Hum Hypertens2003，17，1：	1
15	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus 显示文摘	Haffner SM Greenberg AS Weston WM	2002	Circulation2002，106，6：	1
16	Rosiglitazone reduces urinary albumin excretion in type 2 diabetes 显示文摘	Bakris G Viberti G Weston WM	2003	J Hum Hypertens2003，17，1：	1
17	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus 显示文摘	Haffner SM Greenberg AS Weston WM	2002	Circulation2002，106，12：	1
18	Rosiglitazone reduces urinary albumin excretion in type Ⅱ diabetes显示文摘	Bakris G Viberti G Weston WM	2003	J Hum Hypertens2003，17，1：	1
19	Rosiglitazone onle or twice dailg improves glgcemic cowtrol in patients twith type2 diabetes显示文摘	Granberger G Weston WM Patwardhan R	1999	Diabetes1999，48，1：	1
20	Effect of rosiglitazone treatment on nontraditional Markers of car diovascular disease in patients with type 2 diabetes mellitus显示文摘	Greenberg AS Weston WM	2002	Circulation2002，106，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示